Tags Posts tagged with "Narcotic Treatment Programs in PA during COVID-19 Crisis"

Narcotic Treatment Programs in PA during COVID-19 Crisis

On March 6, 2020, pursuant to the provisions of section 7301(c) of the Emergency Management Services Code, 35 Pa. C.S. §§ 7101, et seq., Governor Tom Wolf issued a Proclamation of Disaster Emergency related to the novel Coronavirus disease (COVID-19). Pursuant to authorization from the Governor in accordance with the proclamation, and consistent with the SAMHSA guidance, the Department of Drug and Alcohol Programs (DDAP) is suspending:

  • Regulation at 28 Pa. Code § 715.9(a)(4), which requires Narcotic Treatment Programs (NTPs) to make a face-to-face determination before admission to treatment, for those clients who will receive buprenorphine treatment. View Licensing Alert 02-20 for more details.
  • Regulation at 28 Pa. Code § 715.6(d), which requires NTPs to have narcotic treatment physician services onsite. View Licensing Alert 03-20 for more details.

Questions regarding these Licensing Alerts can be directed to the Division of Drug and Alcohol Program Licensing at 717-783-8675 or via email.

For further information, please contact Jack Phillips.